A Pharmaceutical Company Spent a Significant Amount of Money Developing

A pharmaceutical company spent a significant amount of money developing a new drug to combat high blood pressure.The drug did not cause any of the typical side effects usually associated with blood pressure medications.It was forecasted to be a "blockbuster" medication that would achieve over $1 billion in sales.It would also be difficult for other firms to duplicate,at least in the short run,because of patent protection and the substantial research and development costs required.The introduction of this new drug would best be described as

A) diversification.
B) market development.
C) a breakthrough opportunity.
D) "hit-or-miss" marketing.
E) market penetration.